Vaccine public comment is due June 17, all of us need access to the latest COVID vaccines
Make your voice heard and ask the CDC to:
- Recommend updated 2024-2025 COVID vaccines for all ages AND
- Strengthen our vaccine drive by recommending more frequent boosting (at least every six months) and more frequent updates to the vaccines, adjusted for the latest variants.
Submit a public comment using our sample language below.
You can also register to give Oral Public Comment at the upcoming June 26-28 online CDC ACIP Meeting at: https://www2.cdc.gov/vaccines/acip/acip_publiccomment.asp
Submit written comments and/or register to make oral comments at the meeting by Monday, June 17 at 11:59pm Eastern Standard Time.
It’s important to submit a personalized comment, which can be brief. Ideas for a personalized comment:
- How you, your family, or your community would be impacted by fall vaccine eligibility being restricted to only high risk groups (such as older age or immunocompromised status)
- Barriers to vaccination your have faced, particularly if your eligibility was questioned or misinterpreted by a vaccine provider
- How out-of-pocket costs are a barrier to getting the latest vaccines
Also feel free to take inspiration from or borrow the language in our sample public comment below.
Docket No. CDC–2024–0043
Updated 2024-2025 COVID vaccines must be recommended for people of all ages, regardless of health status. A restrictive approach to eligibility would create undue barriers for vulnerable people and discourage high risk people from getting needed vaccine boosters.
The vaccine schedule should address waning efficacy in the months following vaccination [1-3] as well as emergence of new SARS-CoV-2 strains by recommending updated vaccination for all ages, at least every six months. Recent vaccination is also associated with a lower risk of developing Long COVID following a COVID infection [4] as well as a lower risk of Multisystem Inflammatory Syndrome in children (MIS-C) [5].
The CDC’s clear and unequivocal recommendation of updated COVID vaccination for all ages will influence what healthcare providers recommend, and what health insurances cover. Moreover, it will improve public awareness regarding the need for updated vaccination.
The CDC must ensure equitable and affordable access to updated vaccines and prevent limited access because of financial constraints or demographics. The CDC’s Bridge vaccine access program is slated to end August 2024 and must be extended to ensure uninsured and underinsured people have access to the updated vaccines this fall [6].
References:
1. Link-Gelles R. Effectiveness of COVID-19 (2023-2024 Formula) vaccines. Presented at: FDA VRBPAC Meeting; June 5, 2024. Accessed June 12, 2024. https://www.fda.gov/media/179140/download
- Wu N, Joyal-Desmarais K, Vieira AM, et al. COVID-19 boosters versus primary series: update to a living review. The Lancet Respiratory Medicine. 2023;11(10):e87-e88. doi:10.1016/S2213-2600(23)00265-5
- Menegale F, Manica M, Zardini A, et al. Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity: A Systematic Review and Meta-analysis. JAMA Netw Open. 2023;6(5):e2310650. doi:10.1001/jamanetworkopen.2023.10650
- Fang Z, Ahrnsbrak R, Rekito A. Evidence Mounts That About 7% of US Adults Have Had Long COVID. JAMA. Published online June 7, 2024. doi:10.1001/jama.2024.11370
- Yousaf AR. Notes from the Field: Surveillance for Multisystem Inflammatory Syndrome in Children — United States, 2023. MMWR Morb Mortal Wkly Rep. 2024;73. doi:10.15585/mmwr.mm7310a2
- https://www.cdc.gov/vaccines/programs/bridge/index.html
Full instructions for written and oral comment and meeting information can be found at: https://www.cdc.gov/vaccines/acip/meetings/index.html
You can also register to give Oral Public Comment at the upcoming June 26-28 online CDC ACIP Meeting at: https://www2.cdc.gov/vaccines/acip/acip_publiccomment.asp
You must register by June 17 at 11:59pm Eastern Standard Time
CDC’s ACIP meeting information on the Federal Register: https://www.federalregister.gov/documents/2024/05/24/2024-11439/meeting-of-the-advisory-committee-on-immunization-practices
Vaccination with the latest updated vaccines continues to be foundational to a multilayered approach to COVID, providing protection against both acute disease and Long COVID. Far too few Americans have received the latest vaccines. Only approximately 22.6% of adults and 14.8% of children have received the latest 2023-2024 vaccines (as of June 1, 2024), which have been available since Fall 2023. COVID vaccination rates in both groups lags far behind influenza vaccination rates. Only 7.1% of adults aged 65 and older received the recommended two doses of the 2023-2024 vaccine (as of April 27, 2024).
Vaccine efficacy wanes significantly four to six months following vaccination, making updated vaccination important for all people as COVID continues to spread in our communities. Vaccine approaches that restrict access based on age or risk status put all of us at risk and leave those at high risk of severe consequences of COVID infection confused about whether they qualify to receive additional doses. A more frequent vaccination approach providing vaccination at least every six months as well as frequent updates to match current variants is needed to better protect all of us amid year-round COVID spread.
The CDC’s Bridge Access Program, which provides COVID vaccines to uninsured and underinsured adults free of charge, is due to end August 2024. The end of this program will unnecessarily put vulnerable people at risk, and public health officials must advocate for continuation and expansion of this program.
Submitted written comments or registration to make oral comments at the meeting must be received by the CDC no later than June 17 at 11:59pm Eastern Standard Time